Sign In
Buy PRVB
$24.98
+0 (+0%)
At Close: Jul 24, 2023
Los Angeles, California--(Newsfile Corp. - June 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Provention Bio, Inc.
New York, New York--(Newsfile Corp. - June 26, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Provention Bio, Inc. ("Provention" or the "Company")(NASDAQ: PRVB) and
New York, New York--(Newsfile Corp. - June 25, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Provention Bio, Inc. (NASDAQ: PRVB) between Novem
3 Biotech Stocks Ready for Big Breakthroughs Like Biogen
03:23pm, Thursday, 24'th Jun 2021
This could be a breakthrough year for these three biotech stocks, resulting in massive gains for their stockholders similar to Biogen. The post 3 Biotech Stocks Ready for Big Breakthroughs Like Biogen
PRVB LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Provention Bio, Inc.
05:25am, Thursday, 24'th Jun 2021
New York, New York--(Newsfile Corp. - June 24, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Provention Bio, Inc. (NAS
New York, New York--(Newsfile Corp. - June 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Provention Bio, Inc. (NASDAQ: PRVB) alle
Provention Bio: PDUFA Ahead, But Uncertainties Abound
02:33pm, Wednesday, 23'rd Jun 2021
The Advisory Committee voted 10-7 favoring an approval recommendation for teplizumab.
New York, New York--(Newsfile Corp. - June 23, 2021) - To: All persons or entities who purchased or otherwise acquired securities of Provention Bio, Inc. ("Provention Bio") (NASDAQ: PRVB) between Nove
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Provention Bio, Inc. (PRVB) Investors
11:00am, Wednesday, 23'rd Jun 2021
LOS ANGELES, June 23, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired
NEW YORK, June 22, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB) and certain of it
New York, New York--(Newsfile Corp. - June 21, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Provention Bio, Inc. (NASDAQ: PRVB) alle
New York, New York--(Newsfile Corp. - June 21, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Provention Bio, Inc. (NASDAQ: PRVB) between Novem
New York, New York--(Newsfile Corp. - June 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
BENSALEM, Pa. , June 21, 2021 /PRNewswire/ -- Law Offices of Howard G.
NEW YORK, June 17, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Provention Bio, Inc. (NASDAQ: PRVB) between November 2, 2020 and
